サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1737275

僧帽弁疾患の世界市場

Mitral Valve Diseases

出版日
ページ情報
英文 384 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
僧帽弁疾患の世界市場
出版日: 2025年05月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 384 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

僧帽弁疾患の世界市場は2030年までに47億米ドルに到達

2024年に31億米ドルと推定される僧帽弁疾患の世界市場は、2024～2030年の分析期間においてCAGR 7.3%で成長し、2030年には47億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである僧帽弁修復治療は、CAGR 9.2%を記録し、分析期間終了時には20億米ドルに達すると予測されます。僧帽弁置換治療セグメントの成長率は、分析期間のCAGRで5.8％と推定されます。

米国市場は8億3,480万米ドル、中国はCAGR11.7%で成長予測

米国の僧帽弁疾患市場は、2024年に8億3,480万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR11.7％を引きずる形で、2030年までに10億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.5％と7.1％と予測されています。欧州では、ドイツがCAGR 4.8%で成長すると予測されています。

世界の僧帽弁疾患市場- 主要動向と促進要因のまとめ

僧帽弁疾患が世界の循環器医療で重要な焦点になりつつある理由とは？

僧帽弁閉鎖不全症（MR）と僧帽弁狭窄症（MS）の両方を含む僧帽弁疾患は、心血管障害の世界のスペクトラムにおいて大きな負担となっています。僧帽弁は左心房と左心室の間に位置し、心臓を通る一方向の血流を制御しています。この弁に構造的または機能的な異常があれば、逆流（漏れ）や狭窄（狭窄）を引き起こし、最終的には心拍出量を低下させ、疲労、呼吸困難、動悸、肺高血圧症などの症状の原因となります。これらの障害を治療せずに放置すると、うっ血性心不全に進行し、死亡リスクが増大します。

高齢化、高血圧や心房細動の増加、画像診断の向上が僧帽弁疾患の発見と有病率の増加に寄与しています。先進諸国では、僧帽弁逸脱に伴う変性MRがより一般的であるが、低所得環境では、早期治療や予防医療へのアクセスが限られているため、リウマチ性僧帽弁狭窄症は依然として根強い問題です。特に、低侵襲の外科手術や経カテーテル治療など、治療法の選択肢が広がっている現在、適時の同定と管理の臨床的重要性は高まっています。

診断および治療の進歩は僧帽弁障害の治療経路をどのように形成しているか？

経胸壁心エコー、経食道心エコー、3D画像、心臓MRIの普及により、僧帽弁疾患の診断状況は著しく改善されました。これらのツールは弁膜の解剖学的構造、弁尖の動き、弁室の大きさ、逆流量を正確に評価することを可能にし、疾患の早期発見と重症度の分類を可能にしています。リスクスコアリングシステムとマルチパラメトリック評価は、現在では治療計画の中心的存在であり、経過観察、薬物管理、インターベンション治療のいずれを選択するかの指針となっています。

重症の僧帽弁疾患に対しては、特に心室機能が保たれている患者に対しては、外科的修復術や置換術が長い間標準的な治療法でした。しかし、MitraClip、PASCAL、ViR/ViMACなどの経カテーテル的僧帽弁インターベンション（TMVI）の技術革新は、開腹手術の適応とならない高リスク患者の治療を大きく変えつつあります。ロボット支援修復術、鎖骨置換システム、環状形成リングの進歩により、手技の安全性と転帰が改善されつつあります。β遮断薬、利尿薬、抗凝固薬などが頻繁に使用され、早期段階や手術不能な患者の症状緩和のための薬理学的管理は依然として重要です。

どのような患者セグメントと地域市場が最も影響を受け、医療需要を牽引しているか？

僧帽弁疾患高齢者、特に65歳以上の患者に不釣り合いな影響を及ぼし、その多くは糖尿病、高血圧、虚血性心疾患などの複数の合併症を有しています。MRは、平均寿命と変性疾患が支配的な新興経済諸国においてより一般的である一方、リウマチ性MSはアフリカ、南アジア、ラテンアメリカの一部では若年人口に影響を与え続けています。さらに、女性の方が僧帽弁逸脱と診断される頻度が高く、高齢になると逆流に進行する可能性があります。

北米と西欧が市場を独占しているのは、確立された循環器インフラ、償還制度、診断普及率の高さによるものです。また、これらの地域はTMVIの導入でもリードしています。アジア太平洋は、人口動態の高齢化、治療能力の向上、構造的心疾患に対する意識の高まりにより、需要が拡大しています。新興市場では、公衆衛生キャンペーン、移動診断装置、リウマチ性心疾患スクリーニングの取り組みが、医療へのアクセス拡大に役立っています。このような取り組みは、僧帽弁疾患が進行するまで診断されないことが多い農村部や十分なサービスを受けていない地域では特に重要です。

僧帽弁疾患世界市場の長期的成長を牽引するものは何か？

僧帽弁疾患市場の成長の原動力は、疾患罹患率の上昇、画像診断とインターベンションの技術進歩、臨床革新と人口動態の高齢化の融合です。心不全プログラム、構造的心臓クリニック、集学的心臓チームの拡大により、より早く、より個別化された治療介入が可能になりつつあります。TMVI装置に対する規制当局の承認と保険償還の増加により、一次および二次MR症例での使用が加速しています。

世界の臨床試験により、特に心不全に伴う機能的MRに対する早期介入のエビデンスが拡大しつつあります。さらに、経カテーテル的僧帽弁置換術（TMVR）デバイスの開発により、解剖学的に複雑な患者や以前は手術不可能であった患者の治療に新たなフロンティアが開かれつつあります。同日退院プロトコル、リアルタイムモニタリング、遠隔心電図検査によるフォローアップなど、患者中心のイノベーションは、長期的なケア提供を改善し、入院コストを削減しています。

心臓病学が予防的、低侵襲的、アウトカム重視のモデルへとシフトする中、僧帽弁疾患管理は、QOL、手技の安全性、ヘルスケア経済性のバランスを取りながら、心臓血管系の技術革新と臨床投資の要であり続けるでしょう。

セグメント

治療タイプ（僧帽弁修復術、僧帽弁置換術、心臓再同期療法、僧帽弁治療薬）;適応症（僧帽弁狭窄症、僧帽弁逸脱症、僧帽弁逆流症）;エンドユーザー（病院、外来手術センター、その他のエンドユーザー）

調査対象企業の例（注目の合計48社）

  • 4C Medical Technologies
  • Abbott Laboratories
  • Affluent Medical
  • Anteris Technologies
  • Artivion, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cadrenal Therapeutics, Inc.
  • Colibri Heart Valve LLC
  • Corcym UK Limited
  • Edwards Lifesciences Corporation
  • HighLife Medical
  • Labcor Laboratorios Ltda
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Micro Interventional Devices, Inc.
  • Novartis AG
  • Zydus Lifesciences Limited

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP34087

Global Mitral Valve Diseases Market to Reach US$4.7 Billion by 2030

The global market for Mitral Valve Diseases estimated at US$3.1 Billion in the year 2024, is expected to reach US$4.7 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Mitral Valve Repair Treatment, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Mitral Valve Replacement Treatment segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$834.8 Million While China is Forecast to Grow at 11.7% CAGR

The Mitral Valve Diseases market in the U.S. is estimated at US$834.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Mitral Valve Diseases Market - Key Trends & Drivers Summarized

Why Are Mitral Valve Diseases Emerging as a Critical Focus in Global Cardiovascular Care?

Mitral valve diseases, encompassing both mitral regurgitation (MR) and mitral stenosis (MS), represent a significant burden in the global spectrum of cardiovascular disorders. The mitral valve-situated between the left atrium and left ventricle-regulates unidirectional blood flow through the heart. Any structural or functional abnormalities in this valve can result in regurgitation (leakage) or stenosis (narrowing), ultimately impairing cardiac output and contributing to symptoms such as fatigue, dyspnea, palpitations, and pulmonary hypertension. Left untreated, these disorders progress to congestive heart failure and increased mortality risk.

Aging populations, rising rates of hypertension and atrial fibrillation, and improved imaging diagnostics are contributing to the increased detection and prevalence of mitral valve diseases. In developed countries, degenerative MR associated with mitral valve prolapse is more common, whereas in lower-income settings, rheumatic mitral stenosis remains a persistent issue due to limited access to early treatment and preventive care. The clinical importance of timely identification and management is growing, particularly with expanding therapeutic options that now include minimally invasive surgical and transcatheter procedures.

How Are Diagnostic and Therapeutic Advancements Reshaping the Treatment Pathway for Mitral Valve Disorders?

The diagnostic landscape for mitral valve diseases has significantly improved with the widespread availability of transthoracic and transesophageal echocardiography, 3D imaging, and cardiac MRI. These tools allow accurate assessment of valvular anatomy, leaflet motion, chamber dimensions, and regurgitant volume, enabling earlier detection and classification of disease severity. Risk scoring systems and multi-parametric evaluations are now central to treatment planning, guiding decisions between watchful waiting, pharmacologic management, and interventional therapy.

Surgical repair or replacement has long been the standard of care for severe mitral valve disease, particularly for patients with preserved ventricular function. However, innovations in transcatheter mitral valve interventions (TMVI), such as MitraClip, PASCAL, and valve-in-ring/valve-in-mitral annular calcification (ViR/ViMAC) procedures, are transforming treatment for high-risk patients who are not candidates for open surgery. Advances in robotic-assisted repair, chordal replacement systems, and annuloplasty rings are improving procedural safety and outcomes. Pharmacological management remains important in earlier stages or for symptomatic relief in non-operable patients, with beta-blockers, diuretics, and anticoagulants being frequently employed.

Which Patient Segments and Geographic Markets Are Most Affected and Driving Care Demand?

Mitral valve diseases disproportionately affect the elderly, particularly individuals above 65 years of age, many of whom present with multiple comorbidities such as diabetes, hypertension, or ischemic heart disease. MR is more prevalent in developed economies where life expectancy and degenerative diseases dominate, while rheumatic MS continues to impact younger populations in parts of Africa, South Asia, and Latin America. Additionally, women are more frequently diagnosed with mitral valve prolapse, which may progress to regurgitation in older age.

North America and Western Europe dominate the market due to well-established cardiovascular infrastructure, reimbursement mechanisms, and high diagnostic penetration. These regions are also leading in TMVI adoption. Asia-Pacific is witnessing growing demand due to aging demographics, increasing procedural capacity, and rising awareness of structural heart disease. In emerging markets, public health campaigns, mobile diagnostic units, and rheumatic heart disease screening initiatives are helping expand access to care. These efforts are especially important in rural and underserved regions, where mitral diseases often go undiagnosed until advanced stages.

What Is Driving Long-Term Growth in the Global Mitral Valve Diseases Market?

The growth in the mitral valve diseases market is driven by rising disease incidence, technological progress in imaging and intervention, and the convergence of clinical innovation with demographic aging. Expansion of heart failure programs, structural heart clinics, and multidisciplinary heart teams is allowing earlier and more personalized treatment interventions. Increasing regulatory approvals and reimbursement coverage for TMVI devices are accelerating their use in both primary and secondary MR cases.

Global clinical trials are expanding the evidence base for early intervention, particularly for functional MR associated with heart failure. Additionally, the development of transcatheter mitral valve replacement (TMVR) devices is unlocking new frontiers in treating anatomically complex or previously inoperable patients. Patient-centric innovations-including same-day discharge protocols, real-time monitoring, and telecardiology follow-ups-are improving long-term care delivery and reducing hospitalization costs.

As cardiology shifts toward preventative, less invasive, and outcomes-focused models, mitral valve disease management is set to remain a cornerstone of cardiovascular innovation and clinical investment-balancing quality of life, procedural safety, and healthcare economics.

SCOPE OF STUDY:

The report analyzes the Mitral Valve Diseases market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy, Mitral Valve Therapeutics); Indication (Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation); End-User (Hospitals, Ambulatory Surgery Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • 4C Medical Technologies
  • Abbott Laboratories
  • Affluent Medical
  • Anteris Technologies
  • Artivion, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cadrenal Therapeutics, Inc.
  • Colibri Heart Valve LLC
  • Corcym UK Limited
  • Edwards Lifesciences Corporation
  • HighLife Medical
  • Labcor Laboratorios Ltda
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Micro Interventional Devices, Inc.
  • Novartis AG
  • Zydus Lifesciences Limited

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Mitral Valve Diseases - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Degenerative and Functional Mitral Valve Diseases Drives Demand for Targeted Therapies
    • Expansion of Aging Global Population Throws the Spotlight on Age-Associated Mitral Regurgitation
    • Advancements in Non-Invasive Imaging Technologies Strengthen Early Diagnosis and Disease Monitoring
    • Growing Adoption of Minimally Invasive Valve Repair and Replacement Procedures Spurs Market Growth
    • Increased Use of Transcatheter Technologies Propels Innovation in Low-Risk Patient Interventions
    • Regulatory Approvals of TMVR Devices Accelerate Access to Novel Therapeutic Modalities
    • Integration of AI and 3D Echocardiography Enhances Accuracy in Mitral Valve Disease Assessment
    • Surge in Demand for Personalized Treatment Planning Drives Growth in Computational Modeling Applications
    • Rising Number of Structural Heart Disease Centers Expands Treatment Accessibility in Emerging Markets
    • Development of Next-Generation Annuloplasty Rings and Clip-Based Repair Devices Sustains Technological Advancements
    • Growing Clinical Evidence Supporting Valve-in-Valve and Valve-in-Ring Procedures Expands Physician Confidence
    • Collaborations Between Cardiology Societies and OEMs Strengthen Best Practice Guidelines for Intervention
    • Shifts Toward Early Intervention Strategies Propels Demand for Screening in Asymptomatic Populations
    • Global Growth in Cardiovascular Disease Awareness Campaigns Drives Preventive Diagnosis Efforts
    • Focus on Long-Term Outcomes and Patient-Reported Quality of Life Sustains Use of Durable Interventions
    • Increasing Investment in Regenerative Valve Research Opens New Frontiers for Biologic Therapies
    • Surge in High-Risk and Inoperable Patient Populations Fuels Demand for Transcatheter Access Routes
    • Improvements in Delivery System Profile and Device Flexibility Enhance Procedural Adoption
    • OEM Support for Surgeon Training and Clinical Education Accelerates Institutional Uptake
    • Reimbursement Expansion for Mitral Valve Procedures Drives Patient and Provider Willingness to Adopt
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mitral Valve Diseases Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mitral Valve Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mitral Valve Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mitral Valve Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Mitral Valve Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mitral Valve Replacement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Mitral Valve Replacement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Mitral Valve Replacement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiac Resynchronization Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cardiac Resynchronization Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Mitral Valve Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Mitral Valve Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Mitral Valve Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Mitral Valve Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Mitral Valve Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Mitral Valve Stenosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Mitral Valve Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Mitral Valve Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Mitral Valve Prolapse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Mitral Valve Regurgitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Mitral Valve Regurgitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Mitral Valve Regurgitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • JAPAN
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • CHINA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • EUROPE
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Mitral Valve Diseases by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • FRANCE
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • GERMANY
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Mitral Valve Diseases by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • INDIA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Mitral Valve Diseases by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Mitral Valve Diseases by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • AFRICA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030

IV. COMPETITION